GreenLight Biosciences receives approval to initiate Phase I/II clinical trial of Covid-19 mRNA vaccine candidate
01 févr. 2023 07h20 HE
|
GreenLight Biosciences
The Rwanda FDA has given regulatory approval to GreenLight to start a Phase I/II clinical trial of its Covid-19 vaccine candidate in Rwanda. This phase I/II clinical trial is the first step in...
Oncotelic Initiates Clinical Trials Evaluating OT-101 against Metastatic Pancreatic Cancer
25 janv. 2023 08h00 HE
|
Oncotelic Therapeutics, Inc.
AGOURA HILLS, Calif., Jan. 25, 2023 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) ("Oncotelic", the "Company" or "We"), a clinical stage biotechnology company, with a planned IPO of...
Exosome Research Global Market Report 2022: Growth in Government and Non-Government Initiatives for Exosome Research Bolsters Sector
20 janv. 2023 05h33 HE
|
Research and Markets
Dublin, Jan. 20, 2023 (GLOBE NEWSWIRE) -- The "Exosome Research Market Share, Size, Trends, Industry Analysis Report, By Product; By Indication; By Application; By Region; Segment Forecast, 2022 -...
Dyadic Announces Sale of Equity Interest in Alphazyme
19 janv. 2023 08h30 HE
|
Dyadic International, Inc.
JUPITER, Fla., Jan. 19, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ("Dyadic", or the "Company") (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
Global Genomics Market Forecasts Report 2023-2027 - Increasing Demand of Specialized/Personalized Medicine Fueling Demand
19 janv. 2023 05h58 HE
|
Research and Markets
Dublin, Jan. 19, 2023 (GLOBE NEWSWIRE) -- The "Genomics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Products & Services (Systems &...
The Worldwide RNA Analysis Industry is Expected to Reach $28 Billion by 2028
11 janv. 2023 07h38 HE
|
Research and Markets
Dublin, Jan. 11, 2023 (GLOBE NEWSWIRE) -- The "Global RNA Analysis Market Size, Share & Industry Trends Analysis Report By Product, By Technology (Real Time-PCR (qPCR) Technology, Sequencing...
Ractigen Therapeutics Announces the Appointment of Harri Järveläinen as Chief Operating Officer
09 janv. 2023 07h00 HE
|
Ractigen Therapeutics
SUZHOU, China, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Ractigen Therapeutics, Inc. announced today that Dr. Harri Järveläinen has been appointed Chief Operating Officer of the Company. "I am thrilled to...
ShapeTX to Showcase Groundbreaking Advances in CNS in vivo RNA Editing, CNS-Targeting AAVs, and TruStable™ AAV Manufacturing at the J.P. Morgan 41st Annual Healthcare Conference
05 janv. 2023 08h00 HE
|
Shape Therapeutics, Inc.
SEATTLE, Jan. 05, 2023 (GLOBE NEWSWIRE) -- ShapeTX today announced Francois Vigneault, Ph.D., Co-founder and Chief Executive Officer, will present at the J.P. Morgan 41st Annual Healthcare...
Global Spatial Genomics & Transcriptomics Global Market Report 2023: Increasing Use of Spatial Omics for Biomarker Identification Boosts Sector
05 janv. 2023 04h53 HE
|
Research and Markets
Dublin, Jan. 05, 2023 (GLOBE NEWSWIRE) -- The "Global Spatial Genomics & Transcriptomics Market by Technique (Spatial Transcriptomics, Spatial Genomics), Product (Instruments, Consumables,...
Global Messenger RNA (mRNA) Vaccines & Therapeutics Market Research Report 2022 Featuring Pfizer, GSK, Daiichi Sankyo, Intellia Therapeutics, Moderna, CureVac, Arcturus Therapeutics, & BioNTech
05 janv. 2023 04h03 HE
|
Research and Markets
Dublin, Jan. 05, 2023 (GLOBE NEWSWIRE) -- The "Messenger RNA (mRNA) Vaccines & Therapeutics Market, Size, Global Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity...